Key statistics
On Friday, Aethlon Medical Inc (AEMD:NAQ) closed at 0.358, 50.74% above the 52 week low of 0.2375 set on Aug 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.392 |
---|---|
High | 0.42 |
Low | 0.3545 |
Bid | 0.3415 |
Offer | 0.3647 |
Previous close | 0.39 |
Average volume | 1.92m |
---|---|
Shares outstanding | 13.94m |
Free float | 13.85m |
P/E (TTM) | -- |
Market cap | 4.99m USD |
EPS (TTM) | -3.87 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India
- Aethlon Medical to Present at Virtual Investor Conferences in September
- Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial
- Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys
- Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update
- Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial
- Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024
- Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update
More ▼